Production of recombinant von Willebrand factor in a bioreactor

Patent metadata

Field	Value
Publication number	US-10829539-B2
Application number	US-201515316870-A
Country	US
Kind code	B2
Filing date	Apr 14, 2015
Priority date	Jun 13, 2014
Publication date	Nov 10, 2020
Grant date	Nov 10, 2020

Abstract

The present invention relates to improved methods for the recombinant production of von Willebrand factor (vWF) in a bioreactor by separating different multimeric forms of vWF with different molecular weight during fermentation.

First claim

The invention claimed is:

1. A process for manufacturing a recombinant von Willebrand factor (vWF), comprising
(a) culturing a cell culture of host cells in a bioreactor in a cell culture medium, wherein the host cells produce recombinant vWF which is secreted into the cell culture medium and wherein the secreted recombinant vWF in the cell culture medium comprises vWF multimers of different sire, wherein at least one cell culture medium component is fed to the cell culture medium, and
(b) pumping the cell culture comprising the host cells, the recombinant vWF, and the cell culture medium over a separation system having a molecular weight cut off size of about 750,000 Da, wherein the separation system separates the vWF multimers into at least
(i) a permeate fraction which is enriched in low molecular weight (LMW) multimers of vWF and reduced in high molecular weight (HMW) multimers of vWF as compared to the vWF multimers in the cell culture supernatant before separation, and
(ii) a retentate fraction which is reduced in multimers of vWF and enriched in multimers of vWF as compared to the vWF multimers in the cell culture supernatant before separation, and
wherein the LMW multimers of vWF corresponds to bands 1 to 5 and the HMW multimers of vWF corresponds to bands 11 and higher as determined in a densitometric vWF analysis.

2. The process according to claim 1 , further comprising harvesting the permeate fraction.

3. The process according to claim 2 , wherein the separation system produces a LMW vWF Multimer Ratio that is equal to or below 0.9.

4. The process according to claim 1 , further comprising harvesting the retentate fraction.

5. The process according to claim 4 , wherein the separation system produces a HMW vWF Multimer Ratio that is equal to or above 1.1.

6. The process according to claim 5 , wherein the recombinant vWF in the retentate fraction has a vWF:RCoF/vWF:Ag ratio above 1.2.

7. The process according to claim 1 , wherein the recombinant vWF is a fusion protein and wherein vWF is fused to albumin or an Fc fragment of an immunoglobulin.

8. The process according to claim 1 , further comprising subjecting the retentate fraction to a second separation, wherein the second separation produces a second permeate fraction and a second retentate fraction, wherein a proportion of ultra-large vWF multimers is enriched in the second retentate fraction and reduced in the second permeate fraction relative, to the proportion of ultra-large, vWF multimers in the total amount of vWF multimer in the retentate fraction before the second separation.

9. The process according to claim 8 , wherein the second separation is performed in parallel with the first separation.

10. The process according to claim 8 , wherein the second separation is performed after the first separation.

11. The process according to claim 8 , wherein the second separation has a molecular weight cut off size of about 10,000,000 Da.

12. The process according to claim 1 , wherein the separation system enriches HMW multimers of vWF in the bioreactor and reduces LMW multimers of vWF in the bioreactor.

Assignees

• Csl Ltd

Inventors

• Debus Stefan
• Lind Holger

Classifications

• C12P21/02

  having a known sequence of two or more amino acids, e.g. glutathione · CPC title

• C07K14/755 Primary

  Factors VIII {, e.g. factor VIII C (AHF), factor VIII Ag (VWF)} · CPC title